NVP-BEZ235, a dual PI3K-mTOR inhibitor, suppresses the growth of FaDu hypopharyngeal squamous cell carcinoma and has a synergistic effect with Cisplatin
Cheng‐Ming Hsu(Chang Gung University), Ming‐Yu Yang(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Cited by 48
Related Papers
Stromal architecture and fibroblast subpopulations with opposing effects on outcomes in hepatocellular carcinoma
|Cell Discovery|2025|48
NVP-BEZ235 Attenuated Cell Proliferation and Migration in the Squamous Cell Carcinoma of Oral Cavities and p70S6K Inhibition Mimics its Effect
|International Journal of Molecular Sciences|2018|14
6-shogaol is a potential treatment for Head and Neck Squamous Cell Carcinoma
|International Journal of Medical Sciences|2023|12
Dihydroisotanshinone I and BMAL-SIRT1 Pathway in an In Vitro 6-OHDA-Induced Model of Parkinson’s Disease
|International Journal of Molecular Sciences|2023|9